-
3385233
nal-IRI
nanoliposomal irinotecan
38
-
3385230
nal-IRI
nanoliposomal formulation of irinotecan
3
-
3385232
nal-IRI
irinotecan and liposomal irinotecan
1
-
3385229
nal-IRI
NAPOLI-1 phase 3 trial, liposomal irinotecan
1
-
3385228
nal-IRI
NAPOLI-1, and whether liposomal irinotecan
1
-
3385231
nal-IRI
PD-EP-NEC (Ki-67>20%; Grade 3) received IV liposomal irinotecan
1